Total non-cash stock compensation expense is $1,337,000, $854,000 and $1,042,000, in 2022, 2021 and 2020, respectively.

At September 25, 2022, we have reserved 279,810 shares of Common Stock for issuance to employees under an incentive and non-statutory stock option and restricted stock plan approved by stockholders of which 279,810 shares are available for granting of non-qualified stock options or issuance of restricted Common Stock.

Options are granted at a price equal to the fair market value on the date of the grant and are exercisable, upon vesting, over a ten-year period.


(Thousands of Shares)	2022	2021	2020

Outstanding, beginning of year	36	41	81
Exercised	(9)	(2)	—
Canceled	(27)	(3)	(40)
Outstanding, end of year	—	36	41
Exercisable, end of year	—	36	41


(Dollars)	2022	2021	2020

Exercised	11.30	11.30	—
Cancelled	11.30	11.30	25.30
Outstanding, end of year	—	11.40	11.40


(Thousands of Shares)	2022	2021	2020

Outstanding, beginning of year	154	155	148
Granted	78	46	72
Vested	(66)	(45)	(61)
Forfeited	(1)	(2)	(4)
Outstanding, end of year	165	154	155

Weighted average grant date fair values of restricted Common Stock are as follows:


(Dollars)	2022	2021	2020

Outstanding, beginning of year	16.70	21.50	24.90
Granted	30.01	11.20	16.20
Vested	20.93	27.30	23.40
Forfeited	23.60	16.10	24.40
Outstanding, end of year	21.21	16.70	21.50

Total unrecognized compensation expense for unvested restricted Common Stock at September 25, 2022 is $1,876,000, which will be recognized over a weighted average period of 1.3 years.

We have 27,000 shares of Common Stock available for issuance pursuant to our Employee Stock Purchase Plan. We also have 870 shares of Common Stock available for issuance under our Supplemental Employee Stock Purchase Plan. There has been no activity under these plans in 2022, 2021, or 2020.